What is LOPJLB’s current signal on ORKA?

LOPJLB’s latest quantitative signal on Oruka Therapeutics, Inc. (ORKA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ORKA in?

Oruka Therapeutics, Inc. (ORKA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Oruka Therapeutics, Inc. (ORKA) do?

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleuki…

Where is Oruka Therapeutics, Inc. based / listed?

Oruka Therapeutics, Inc. is based in US, listed on NASDAQ.

Oruka Therapeutics, Inc. (ORKA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$82.11+6.25%Close

SELLCRISIS · day 3

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $3.1B
Beta: -0.39
P/E (TTM): -32.46

Short % float: 29.38%
Days to cover: 6.3
SI change: +2.0%

1W: -2.85%
1M: -10.41%

vs SPY 1W: -4.01%
vs SPY 1M: -13.40%

Industry peers

FMP comparable companies · ranked by market cap

DNTHSELLDianthus Therapeutics, Inc.$4.6BCRISISQ 2$82.43-0.07%
XNCRSELLXencor, Inc.$1.8BRECOVERYQ 15$24.50+0.53%
ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$46.21-0.56%
MLTXSELLMoonLake Immunotherapeutics$890MCRISISQ -0$10.58+2.27%
ODTXSELLOdyssey Therapeutics, Inc.$870MQ 38$18.12+4.86%
ALMSSELLAlumis Inc.$860MCRISISQ 2$6.97+2.73%
ATTOSELLAttovia Therapeutics, Inc.$702MQ -44$16.31-0.61%
ACRSSELLAclaris Therapeutics, Inc.$529MCRISISQ 9$3.79+1.06%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news